Sibopirdine
Alternative Names: DUP 921; EXP 921Latest Information Update: 08 Jul 2008
At a glance
- Originator Bristol-Myers Squibb
- Class Neuroprotectants; Nootropics
- Mechanism of Action Acetylcholine stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease
Most Recent Events
- 08 Jul 2008 Discontinued - Preclinical for Alzheimer's disease in USA (unspecified route)
- 08 Jul 1998 No-Development-Reported for Alzheimer's disease in USA (Unknown route)
- 28 Nov 1994 Preclinical development for Alzheimer's disease in USA (Unknown route)